EMZ-701

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameEMZ-701

Drug Alias NameMS-I.E.T.IFN-β + EMZ701Interferon-enhancing therapy for multiple sclerosis - Transition TherapeuticsEMZ701 + interferon-βInterferon-beta/EMZ 701 +[7]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterferon beta stimulants

TargetsInterferon beta

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTransition Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTransition Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A